🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: bionet.software
Article #2358

New Targets and Drug Modalities

#2358
From: James Prudhomme
Date: Tue, 19 Apr 2011 18:23
52 lines
4279 bytes
CHI and Bio-IT World's "Structure-Based Design" Conference to be held on
June 8-10, 2011 in Cambridge, MA, will 
feature a new session:  New Targets and Drug Modalities.

The following presentations have just been added and are scheduled on
Friday, June 10 from 1:30-3:50 p.m.

Structure-Based Ligand Discovery for GPCRs
Ruben Abagyan, Ph.D., Professor, Skaggs School of Pharmacy and
Pharmaceutical Sciences, University of California,
San Diego

The Role of Recent Crystal Structures of Membrane Bound Proteins in Drug
Discovery for CNS Targets
Sid Topiol, Ph.D., CSO, Computational and Structural Investigations,
3D-2Drug

Hitting a Moving Target: Characterizing GPCR Signaling through
Long-timescale Molecular Dynamics Simulations
Ron Dror, Ph.D., Senior Research Scientist and Special Advisor to the
Chairman, D. E. Shaw Research

Beyond the Orthosteric Binding Site: A Structure-Based SAR Analysis of the
D3R Selective Compounds
Lei Shi, Ph.D., Assistant Professor, Department of Physiology and
Biophysics, HRH Prince Alwaleed Bin Talal Bin 
Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell
Medical College

Moving in New Circles - Exploiting Macrocycles for Drug Discovery
Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp.

View full details and register at: http://www.healthtech.com/sbd or call
781-972-5400.

Those that register by April 29 will receive the advanced registration
discount. 

***

James Prudhomme
Marketing Manager
Cambridge Healthtech Institute
250 First Avenue, Suite 300
Needham, MA 02494
Tel: 781-972-5486
Fax: 781-972-5425
www.healthtech.com

 

 
Technical Details
Message-ID: <mailman.823.1303237666.20886.bio-soft@net.bio.net>
Path: arc1-ca.pugleaf.net!g2news2.google.com!news2.google.com!Xl.tags.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!local2.nntp.dca.giganews.com!news.giganews.com.POSTED!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: fa6b6,8cf438791b464d7e,start
X-Google-NewGroupId: yes
X-Google-Attributes: gid6710630482,domainid0,public,usenet
X-Google-Language: ENGLISH,ASCII-7-bit
Path: arc1-ca.pugleaf.net!g2news2.google.com!news2.google.com!Xl.tags.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!local2.nntp.dca.giganews.com!news.giganews.com.POSTED!not-for-mail
NNTP-Posting-Date: Tue, 19 Apr 2011 13:28:14 -0500
X-Envelope-From: jprudhomme@healthtech.com
From: "James Prudhomme" <jprudhomme@healthtech.com>
To: <Bio-soft@magpie.bio.indiana.edu>
Date: Tue, 19 Apr 2011 14:23:30 -0400
MIME-Version: 1.0
X-Mailer: Microsoft Office Outlook 12.0
Thread-Index: Acv+vuFIqQK3A3BkRaKmmwAHSRQp6A==
Content-Language: en-us
x-cr-hashedpuzzle: AgrN AhDI Bgz9 BzSw CJ2+ DYLc D5FL FByY FYMF GAIC Gyzg G7yq
 HqZK HxXy IN7W KP7P; 1;
 YgBpAG8ALQBzAG8AZgB0AEAAbgBlAHQALgBiAGkAbwAuAG4AZQB0AA==;
 Sosha1_v1; 7; {1F2D3C97-774B-42B6-9AD2-93A901FD1A5B};
 agBwAHIAdQBkAGgAbwBtAG0AZQBAAGgAZQBhAGwAdABoAHQAZQBjAGgALgBjAG8AbQA=;
 Tue, 19 Apr 2011 18:23:28 GMT;
 TgBlAHcAIABUAGEAcgBnAGUAdABzACAAYQBuAGQAIABEAHIAdQBnACAATQBvAGQAYQBsAGkAdABpAGUAcwA=
x-cr-puzzleid: {1F2D3C97-774B-42B6-9AD2-93A901FD1A5B}
X-Originating-IP: [66.228.71.161]
X-AntiSpam: Checked for restricted content by Gordano's AntiSpam Software
X-Mailman-Approved-At: Tue, 19 Apr 2011 13:27:44 -0500
Content-Type: text/plain;
 charset="us-ascii"
Content-Transfer-Encoding: 7bit
X-Content-Filtered-By: Mailman/MimeDel 2.1.4
X-BeenThere: bio-soft@net.bio.net
X-Mailman-Version: 2.1.4
Precedence: list
Organization: BIOSCI/IUBio, Biology Dept., Indiana University
subject: New Targets and Drug Modalities
Newsgroups: bionet.software
Message-ID: <mailman.823.1303237666.20886.bio-soft@net.bio.net>
Approved: BIOSCI Approval Key <biosci-approval-key@net.bio.net>
X-Auth: PGPMoose V1.1 PGP bionet.software
 iQCVAwUBTa3UI6CIqsWvyF5FAQGkGAQAoE+zYevtE2M+5OcVWohhRnwBF0Jtmdq/
 6FaM2zy+N4tOLkSoJhZRlI+81xw28hiusrg9NeMBSe7fHnIz3Kd38k+ZkCyT6nIQ
 SIkM9DHNQ9gc0O1nUV1VxDw7u4D8qzje8j8Ea+0X61HTuUh3ghEWqMtB8v9CST6i
 uos/uEyv6Yk= =Vusu
Lines: 53
X-Usenet-Provider: http://www.giganews.com
X-Trace: sv3-hkAXx9z+mxxVh3a+ZVNc+ohPgLPOv9Awcu16YDZeE5/bFy0TyIqhKsa3SkslRjlk2tjgqC+84RIGPPx!F18VEQDKmjijW/3naoH08x+Ced+XShZ5vwaHX3hiofYDVLJwpPbZZczQZxKJ6c5wCzkQ+L2DO8mo!WO9kSg==
X-Complaints-To: abuse@giganews.com
X-DMCA-Notifications: http://www.giganews.com/info/dmca.html
X-Abuse-and-DMCA-Info: Please be sure to forward a copy of ALL headers
X-Abuse-and-DMCA-Info: Otherwise we will be unable to process your complaint properly
X-Postfilter: 1.3.40
X-Original-Bytes: 3983